About: Laurent Bertoletti

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Laurent Bertoletti Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Bertoletti, Laurent (1978-....) Bertoletti, Laurent (1978-....) Bertoletti, Laurent (1978-....) Bertoletti, Laurent (1978-....)
Life Event	http://www.idref.fr/116915854/birth
preferred label	Bertoletti, Laurent (1978-....)
name	Laurent Bertoletti
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000001891723
Given name	Laurent
familyName	Bertoletti
has biographical i...tion (Deprecated)	Vice-président de l'AJPO (Association des jeunes pneumologues), responsable de la formation auteur d'une thèse d'exercice à la faculté de médecine de Saint-Etienne
gender	male
ORCID iD	0000-0001-8214-3010
is sameAs of	Bertoletti, Laurent (1978-....) Bertoletti, Laurent (1978-....) Bertoletti, Laurent (1978-....) Bertoletti, Laurent (1978-....)
is Thesis advisor of	http://www.sudoc.fr/179278134/id http://www.sudoc.fr/197077951/id http://www.sudoc.fr/203039440/id http://www.sudoc.fr/192632833/id http://www.sudoc.fr/18108032X/id http://www.sudoc.fr/203059247/id http://www.sudoc.fr/203087240/id http://www.sudoc.fr/22879269X/id http://www.sudoc.fr/259024759/id http://www.sudoc.fr/224330128/id http://www.sudoc.fr/233629807/id http://www.sudoc.fr/276830318/id http://www.sudoc.fr/219843120/id http://www.sudoc.fr/263516318/id http://www.sudoc.fr/233247270/id http://www.sudoc.fr/240249747/id http://www.sudoc.fr/263089371/id http://www.sudoc.fr/233990666/id http://www.sudoc.fr/242260926/id http://www.sudoc.fr/279236816/id http://www.sudoc.fr/231477899/id http://www.sudoc.fr/273378449/id http://www.sudoc.fr/278591108/id
is Praeses of	http://www.sudoc.fr/26912957X/id
is Author of	Pneumologie http://www.sudoc.fr/16067879X/id http://www.sudoc.fr/143858491/id http://www.sudoc.fr/152063005/id Questions non résolues sur la maladie thrombo-embolique veineuse. Consensus de la Société française de médecine vasculaire (SFMV) https://hal.archives-ouvertes.fr/hal-03187607#id Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV) Benefit of Risk Score-Guided Prophylaxis in Pregnant Women at Risk of Thrombotic Events: A Controlled Before-and-After Implementation Study “Rehab for all!” Is it too early in pulmonary arterial hypertension? Echocardiography and PESI have independent prognostic role in pulmonary embolism. Should we screen for pulmonary hypertension at the initial evaluation of idiopathic pulmonary fibrosis? Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry. Initial dual oral combination therapy in pulmonary arterial hypertension https://serval.unil.ch/notice/serval:BIB_2966AF5192BA#id Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte. Version courte Association between Leflunomide and Pulmonary Hypertension Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry Prognostic value of the Geneva prediction rule in patients in whom pulmonary embolism is ruled out. COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach Management of superficial venous thrombosis in unevaluated situations: Cancer, severe renal impairment, pregnancy and post-partum https://serval.unil.ch/notice/serval:BIB_FBBA183D678A#id Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis Effect of Activated Charcoal on Rivaroxaban Complex Absorption. Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism https://archive-ouverte.unige.ch/unige:32985#id https://archive-ouverte.unige.ch/unige:174223#id Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial Facteurs de risque de maladie veineuse thromboembolique chez les jeunes femmes en contexte hormonal Effects of impaired renal function on levels and performance of D-dimer in patients with suspected pulmonary embolism. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism https://serval.unil.ch/notice/serval:BIB_2D5510CF4FDE#id Areas of improvement in anticoagulant safety. Data from the CACAO study, a cohort in general practice Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: a post-hoc analysis of the PADIS-PE trial Prognostic value of the Geneva prediction rule in patients with pulmonary embolism. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism Cancer incidence in patients with pre-capillary pulmonary hypertension Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism https://orbi.uliege.be/handle/2268/315500#id https://serval.unil.ch/notice/serval:BIB_5235AEC57B36#id Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial? Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism https://serval.unil.ch/notice/serval:BIB_AFB9689A0B8A#id https://archive-ouverte.unige.ch/unige:23978#id https://archive-ouverte.unige.ch/unige:73909#id https://serval.unil.ch/notice/serval:BIB_F8F78DB93C6E#id

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software